Synergy CHC earnings release, May 14, 2026

Synergy CHC Corp. (SNYRQ) · Form 8-K, Item 2.02 · Filed · SEC filing

Synergy CHC Corp. Reports First Quarter 2026

Financial Results

N. WINDHAM, Maine, May 14, 2026 – Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a consumer health and wellness company, is announcing its financial results for the three months ended March 31, 2026.

“Our first quarter results reflect continued execution and the growing momentum of our functional beverage business,” said Jack Ross, CEO of Synergy CHC Corp. “During the quarter, we generated over $650,000 in functional beverage revenue, exceeding our total beverage revenue for all of 2025. This performance reflects the success of our expanding retail and distribution partnerships across the U.S., supported by healthy sell-through that is already driving increased reorder activity. Reflecting this momentum, our beverage division is operating at an estimated annual run rate exceeding $4 million. With this foundation in place and continued expansion of our distribution footprint underway, we believe we are well-positioned to capture the significant growth opportunities emerging within the functional beverage sector. With solid early-year momentum and a clear strategic path, we expect 2026 to be a year of sustainable growth and value creation for our shareholders.”

First Quarter 2026 Financial Summary vs. Same

Year-Ago Period

First Quarter 2026 Financial Results

Revenue in the first quarter of 2026 was $5.49 million compared to $8.17 million in the first quarter of 2025, due to license revenue of $1.5 million in 2025 that did not repeat in

2026 and out-of-stock dynamics for several key online items in our Flat Tummy brand, which impacted online sales. This was partially offset by strong performance in beverages, which delivered significantly higher revenue compared to the prior year period.

Gross margin in the first quarter of 2026 was

72.3% compared to 75.4% in the first quarter of 2025. Excluding license revenue from the first quarter of 2025, normalized gross margin for that period was 70.0%, a 2.3% improvement year-over-year.

Operating expenses in the first quarter of 2026 were $4.54 million compared to $4.22 million in the first quarter of 2025, reflecting higher overhead associated with the expansion of the beverage business.

Income (loss) from operations for the first quarter of 2026 was ($0.57) million compared to $1.95 million in the first quarter of 2025, which is largely due to the license revenue of $1.5 million in 2025 that did not repeat in 2026 and increased overhead costs.

Net income (loss) in the first quarter of 2026 was ($2.57) million compared to net income of $0.88 million in the first quarter of 2025.

Earnings (loss) per share in the first quarter of 2026 was ($0.23) compared to $0.10 in the first quarter of 2025.

EBITDA (loss) (a non-GAAP financial measure) in the first quarter of 2026 was ($0.54) million compared to $1.98 million in the first quarter of 2025.

Adjusted EBITDA (loss) (a non-GAAP financial measure) in the first quarter of 2026 was ($0.35) million compared to $1.98 million in the first quarter of 2025.

Balance Sheet and Cash Flow

As of March 31, 2026, Synergy had approximately

$0.30 million in cash and cash equivalents, compared to $2.6 million in cash and cash equivalents as of December 31, 2025. Subsequent to quarter-end, Synergy raised approximately $2.7 million in gross proceeds through its at-the-market (ATM) equity offering program.

As of March 31, 2026, Synergy had a working capital deficit of $0.50 million, compared to a $1.78 million working capital surplus as of December 31, 2025.

As of March 31, 2026, Synergy had $3.4 million in inventory, compared to $3.7 million in inventory as of December 31, 2025.

Cash used in operating activities for the three months ended March 31, 2026 was $2.0 million compared to cash used in operating activities of $0.82 million for the three months ended

March 31, 2025.

Non-GAAP Financial Measure Reconciliation:

EBITDA and Adjusted EBITDA

To assist financial statement users in an assessment of our historical performance, the Company discloses non-GAAP financial measures in press releases and on investor conference calls and related events, as the Company believes that the non-GAAP information enhances investors’ overall understanding of our financial performance, and should be read in addition to, rather than instead of, the financial statements prepared in accordance with GAAP.

Management believes EBITDA and Adjusted EBITDA provide useful information to investors by excluding certain items that may not be indicative of the Company’s core operating results and that can vary significantly between periods. EBITDA is defined as net income plus interest expense, income tax expense, depreciation and amortization. Adjusted EBITDA is calculated as EBITDA plus or minus foreign exchange gains or losses, one-time expenses and non-cash expenses. Since Adjusted EBITDA is a non-GAAP financial performance measure, the Company’s calculation of Adjusted EBITDA may not be comparable to other similarly titled measures of other companies; and should not be considered in isolation, as a substitute for, or superior to measures of financial performance prepared in accordance with GAAP.²

The following table reconciles net income to EBITDA and Adjusted EBITDA (in millions of US dollars):

About Synergy CHC Corp.

Synergy CHC Corp. develops and markets consumer health and wellness products, led by its flagship brands FOCUSfactor® and Flat Tummy®. FOCUSfactor®, a clinically studied brain health supplement and functional beverage line with a 25-year legacy, enjoys established distribution in the

U.S., Canada and Mexico, through major retailers including Costco, Walmart, Amazon, BJ’s, and Walgreens, among others. Flat Tummy® complements... (truncated)s and weight management.

Forward Looking Statements

Financial statements

Income Statement

For the three months ended — Unaudited Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income

For the three months ended – March 31, 2026For the three months ended – March 31, 2025
RevenueProduct Sales5,492,7056,670,534
RevenueLicense Revenue1,500,000
RevenueTotal Revenue5,492,7058,170,534
RevenueCost of Sales1,521,9102,006,513
RevenueGross Profit3,970,7956,164,021
Operating expensesSelling and marketing2,455,7322,876,271
Operating expensesGeneral and administrative2,048,8501,306,714
Operating expensesDepreciation and amortization33,33333,333
Operating expensesTotal operating expenses4,537,9154,216,318
Operating expenses(Loss) Income from operations-567,1201,947,703
Other (income) expensesInterest income-340-13,882
Other (income) expensesInterest expense2,012,1211,095,369
Other (income) expensesRemeasurement loss on translation of foreign subsidiary3,7181,412
Other (income) expensesTotal other expenses2,015,4991,082,899
Other (income) expensesNet (loss) income before income taxes-2,582,619864,804
Other (income) expensesIncome tax benefit13,72011,460
Other (income) expensesNet (loss) income after tax-2,568,899876,264
Other (income) expensesNet (loss) income per share – basic-0.230.1
Other (income) expensesNet (loss) income per share – diluted-0.230.1
Weighted average common shares outstandingBasic11,303,8538,560,636
Weighted average common shares outstandingDiluted11,303,8538,577,620
Comprehensive (loss) income:Net (loss) income-2,568,899876,264
Comprehensive (loss) income:Foreign currency translation adjustment22,080-1,935
Comprehensive (loss) income:Comprehensive (loss) income-2,546,819874,329

Balance Sheet

March 31, 2026 — Condensed Consolidated Balance Sheets

March 31, 2026 – (unaudited)December 31, 2025
Current AssetsCash and cash equivalents292,1152,622,313
Current AssetsRestricted cash100,000100,000
Current AssetsAccounts receivable, net1,268,0223,203,505
Current AssetsPrepaid expenses (including related party amount of $652,270 and $110,803, respectively)1,303,173351,049
Current AssetsInventory, net3,381,6143,737,509
Current AssetsTotal Current Assets6,344,92410,014,376
Current AssetsIntangible assets, net116,667150,000
Current AssetsTotal Assets6,461,59110,164,376
Current Liabilities:Accounts payable and accrued liabilities (including payable to shareholder of $193,641 and $197,512, respectively)4,031,9946,388,219
Current Liabilities:Income taxes payable85,81188,108
Current Liabilities:Contract liabilities1,526
Current Liabilities:Short term loans payable, net of debt discount, related party100,000
Current Liabilities:Current portion of notes payable, net of debt discount2,730,9811,658,215
Current Liabilities:Total Current Liabilities6,848,7868,236,068
Long-term Liabilities:Notes payable, net of debt discount25,018,05525,056,446
Long-term Liabilities:Total long-term liabilities25,018,05525,056,446
Long-term Liabilities:Total Liabilities31,866,84133,292,514
Stockholders’ Deficit:Common stock, $0.00001 par value; 300,000,000 shares authorized; 11,483,926 shares issued; 11,303,853 outstanding114114
Stockholders’ Deficit:Additional paid in capital33,710,85733,594,550
Stockholders’ Deficit:Common stock to be issued153,400
Stockholders’ Deficit:Accumulated other comprehensive loss-132,201-154,281
Stockholders’ Deficit:Accumulated deficit-59,009,920-56,441,021
Stockholders’ Deficit:Less: Treasury stock (180,073 shares) at cost-127,500-127,500
Stockholders’ Deficit:Total stockholders’ deficit-25,405,250-23,128,138
Stockholders’ Deficit:Total Liabilities and Stockholders’ Deficit6,461,59110,164,376

Cash Flow

For the three months ended — Unaudited Condensed Consolidated Statements of Cash Flows

For the three months ended – March 31, 2026For the three months ended – March 31, 2025
Cash Flows from Operating ActivitiesNet (loss) income-2,568,899876,264
Adjustments to reconcile net (loss) income to net cash used in operating activities:Amortization of debt discount and debt issuance cost951,942406,841
Adjustments to reconcile net (loss) income to net cash used in operating activities:Depreciation and amortization33,33333,333
Adjustments to reconcile net (loss) income to net cash used in operating activities:Stock based compensation116,307
Adjustments to reconcile net (loss) income to net cash used in operating activities:Foreign currency transaction loss (gain)2,684-3,137
Adjustments to reconcile net (loss) income to net cash used in operating activities:Remeasurement loss (gain) on translation of foreign subsidiary3,718-1,412
Changes in operating assets and liabilities:Accounts receivable1,935,483940,519
Changes in operating assets and liabilities:Other receivables144,637
Changes in operating assets and liabilities:Loan receivable, related party-833
Changes in operating assets and liabilities:Inventory355,895-629,935
Changes in operating assets and liabilities:Prepaid expenses-410,657-114,787
Changes in operating assets and liabilities:Prepaid expense, related party-541,467-195,913
Changes in operating assets and liabilities:Income taxes payable-2,297-165,413
Changes in operating assets and liabilities:Contract liabilities-1,526-24,216
Changes in operating assets and liabilities:Accounts payable and accrued liabilities-1,915,323-2,218,041
Changes in operating assets and liabilities:Accounts payable, related party-3,871129,312
Full release

Certain statements contained in this press release constitute “forward-looking statements,” including statements regarding brand expansion and growth initiatives. These forward-looking statements represent Synergy’s expectations or beliefs concerning future events, and it is possible that the results described in this press release will not be achieved. These forward-looking statements are subject to risks, uncertainties and other factors, which are set forth in Synergy’s registration statement on Form S-1, as amended, many of which are outside of Synergy’s control, that could cause actual results to differ materially from the results discussed in the forward-looking statements.

Any forward-looking statement speaks only as of the date on which it is made, and, except as required by law, Synergy does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for Synergy to predict all such factors. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements in Synergy’s filings with the SEC. The risk factors and other factors noted in Synergy’s filings could cause its actual results to differ materially from those contained in any forward-looking statement.

Investor Relations

Gateway Group

Cody Slach, Greg Robles

949.574.3860

SNYR@gateway-grp.com³

Synergy CHC Corp.

Condensed Consolidated Balance Sheets⁴

Synergy CHC Corp.

Unaudited Condensed Consolidated Statements of

Operations and Comprehensive (Loss) Income⁵

Synergy CHC Corp.

Unaudited Condensed Consolidated Statements of

Cash Flows⁶

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Synergy CHC earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.